HighCom (HCL) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
2 Mar, 2026Executive summary
Specialist in advanced ballistic protection and integrated defense technology, serving military, law enforcement, and commercial sectors globally.
Structured into Armor (body armor, helmets, shields) and Technology (UAS, counter-UAS, integration, and training) divisions.
Recent management refresh and strategic shift to US-produced products, sharpening operational focus.
Revenue declined 59% year-over-year to $10.9m for H1 FY26, mainly due to US government shutdown and tariff uncertainty affecting the Armor segment.
HighCom Technology performed to plan, delivering engineering and support services, while Armor faced market headwinds.
Financial highlights
H1 FY26 revenue was $10.9 million, down from $26.6 million year-over-year, with EBITDA loss of $5.4 million, within guidance.
Net loss after tax was $6.8 million (prior year: $1.2 million profit); gross profit $1.3 million (prior year: $6.8 million).
Tax expense of $686,000 related to prior years and currency impact of $232,000 included in results.
Inventory reduced to $12.5 million from $14.4 million at 30 June 2025; $1.1 million converted to cash.
New impairment of $655,000 on delayed bid; reversal of $580,000 previously impaired inventory.
Outlook and guidance
Expecting 100–150% revenue uplift in H2 FY26 vs. H1, aiming for break-even or slight profit.
Recovery in US government funding anticipated to normalize by Q4 H2 FY26.
Key dependencies: timing of large technology order, US government market recovery, and exchange rates.
FY27 outlook strong with robust pipeline and capacity to meet growth.
Opportunity pipeline for Armor exceeds US$55 million for H2 FY26.
Latest events from HighCom
- Revenue fell 49% to $45.3m with a $12m net loss, but H2 EBITDA turned positive.HCL
H2 202426 Mar 2026 - Capital raise supports growth, XTclave® upgrades, and a return to profitability in H2 FY26.HCL
Investor presentation11 Feb 2026 - Achieved positive EBITDA and margin recovery, with new products set to drive FY26 growth.HCL
H2 202523 Nov 2025